Ignite Creation Date:
2024-05-06 @ 3:31 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04652700
Status:
COMPLETED
Last Update Posted:
2023-08-21
First Post:
2020-12-02
Brief Title:
Oral Islatravir MK-8591 Once-Monthly as Preexposure Prophylaxis PrEP in Men and Transgender Women Who Are at High Risk for HIV-1 Infection MK-8591-024
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-04
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-02
First Submit QC Date:
December 2 2020
Study First Post Date:
2020-12-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-16
Last Update Post Date:
2023-08-21
Last Update Post Date Type:
ACTUAL